US Stock MarketDetailed Quotes

PDSB PDS Biotechnology

Watchlist
  • 3.270
  • +0.010+0.31%
Close Apr 26 16:00 ET
  • 3.360
  • +0.090+2.75%
Post 19:39 ET
119.94MMarket Cap-2352P/E (TTM)

PDS Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
3.29%43.05M
-44.71%10.41M
44.52%10.52M
79.00%12.7M
11.12%9.42M
94.37%41.67M
197.73%18.82M
4.55%7.28M
38.91%7.09M
178.07%8.48M
Selling and administrative expenses
24.84%15.28M
10.31%2.94M
39.13%4.07M
40.84%4.69M
7.86%3.58M
20.19%12.24M
-9.08%2.67M
-10.63%2.93M
42.24%3.33M
102.78%3.32M
-General and administrative expense
24.84%15.28M
10.31%2.94M
39.13%4.07M
40.84%4.69M
7.86%3.58M
20.19%12.24M
-9.08%2.67M
-10.63%2.93M
42.24%3.33M
102.78%3.32M
Research and development costs
-5.67%27.76M
-53.79%7.47M
48.14%6.45M
112.80%8M
13.22%5.84M
161.50%29.43M
376.65%16.16M
18.03%4.35M
36.08%3.76M
265.26%5.16M
Operating profit
-3.29%-43.05M
44.71%-10.41M
-44.52%-10.52M
-79.00%-12.7M
-11.12%-9.42M
-94.37%-41.67M
-197.73%-18.82M
-4.55%-7.28M
-38.91%-7.09M
-178.07%-8.48M
Net non-operating interest income expense
-241.69%-1.3M
-55.30%-491.25K
-126.83%-329.48K
-428.31%-244.74K
-4,266.74%-237.5K
-8,874.48%-381.34K
-18,395.60%-316.33K
-10,796.17%-145.25K
12,242.22%74.55K
770.23%5.7K
Non-operating interest income
210.42%2.9M
13.38%683.54K
193.33%739.4K
906.95%750.65K
12,695.46%729.34K
21,418.18%935.18K
34,767.67%602.86K
18,462.08%252.07K
12,242.22%74.55K
770.23%5.7K
Non-operating interest expense
219.47%4.21M
27.81%1.17M
169.02%1.07M
--995.4K
--966.85K
--1.32M
--919.19K
--397.33K
--0
--0
Other net income (expense)
Income before tax
-5.46%-44.35M
43.05%-10.9M
-46.13%-10.85M
-84.39%-12.94M
-14.00%-9.66M
-96.19%-42.05M
-202.81%-19.14M
-6.66%-7.42M
-37.46%-7.02M
-177.95%-8.47M
Income tax
-17.28%-1.41M
2
0
-17.28%-1.41M
73.45%-1.2M
0
0
73.45%-1.2M
Net income
-5.11%-42.94M
43.05%-10.9M
-46.13%-10.85M
-98.22%-11.53M
-14.00%-9.66M
-141.48%-40.85M
-202.81%-19.14M
-6.66%-7.42M
-888.10%-5.82M
-177.95%-8.47M
Net income continuous Operations
-5.11%-42.94M
43.05%-10.9M
-46.13%-10.85M
-98.22%-11.53M
-14.00%-9.66M
-141.48%-40.85M
-202.81%-19.14M
-6.66%-7.42M
-888.10%-5.82M
-177.95%-8.47M
Minority interest income
Net income attributable to the parent company
-5.11%-42.94M
43.05%-10.9M
-46.13%-10.85M
-98.22%-11.53M
-14.00%-9.66M
-141.48%-40.85M
-202.81%-19.14M
-6.66%-7.42M
-888.10%-5.82M
-177.95%-8.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-5.11%-42.94M
43.05%-10.9M
-46.13%-10.85M
-98.22%-11.53M
-14.00%-9.66M
-141.48%-40.85M
-202.81%-19.14M
-6.66%-7.42M
-888.10%-5.82M
-177.95%-8.47M
Basic earnings per share
2.80%-1.39
47.76%-0.35
-34.62%-0.35
-85.00%-0.37
0.00%-0.32
-116.67%-1.43
-191.30%-0.67
-8.33%-0.26
-566.67%-0.2
-128.57%-0.32
Diluted earnings per share
2.80%-1.39
47.76%-0.35
-34.62%-0.35
-85.00%-0.37
0.00%-0.32
-116.67%-1.43
-191.30%-0.67
-8.33%-0.26
-566.67%-0.2
-128.57%-0.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 3.29%43.05M-44.71%10.41M44.52%10.52M79.00%12.7M11.12%9.42M94.37%41.67M197.73%18.82M4.55%7.28M38.91%7.09M178.07%8.48M
Selling and administrative expenses 24.84%15.28M10.31%2.94M39.13%4.07M40.84%4.69M7.86%3.58M20.19%12.24M-9.08%2.67M-10.63%2.93M42.24%3.33M102.78%3.32M
-General and administrative expense 24.84%15.28M10.31%2.94M39.13%4.07M40.84%4.69M7.86%3.58M20.19%12.24M-9.08%2.67M-10.63%2.93M42.24%3.33M102.78%3.32M
Research and development costs -5.67%27.76M-53.79%7.47M48.14%6.45M112.80%8M13.22%5.84M161.50%29.43M376.65%16.16M18.03%4.35M36.08%3.76M265.26%5.16M
Operating profit -3.29%-43.05M44.71%-10.41M-44.52%-10.52M-79.00%-12.7M-11.12%-9.42M-94.37%-41.67M-197.73%-18.82M-4.55%-7.28M-38.91%-7.09M-178.07%-8.48M
Net non-operating interest income expense -241.69%-1.3M-55.30%-491.25K-126.83%-329.48K-428.31%-244.74K-4,266.74%-237.5K-8,874.48%-381.34K-18,395.60%-316.33K-10,796.17%-145.25K12,242.22%74.55K770.23%5.7K
Non-operating interest income 210.42%2.9M13.38%683.54K193.33%739.4K906.95%750.65K12,695.46%729.34K21,418.18%935.18K34,767.67%602.86K18,462.08%252.07K12,242.22%74.55K770.23%5.7K
Non-operating interest expense 219.47%4.21M27.81%1.17M169.02%1.07M--995.4K--966.85K--1.32M--919.19K--397.33K--0--0
Other net income (expense)
Income before tax -5.46%-44.35M43.05%-10.9M-46.13%-10.85M-84.39%-12.94M-14.00%-9.66M-96.19%-42.05M-202.81%-19.14M-6.66%-7.42M-37.46%-7.02M-177.95%-8.47M
Income tax -17.28%-1.41M20-17.28%-1.41M73.45%-1.2M0073.45%-1.2M
Net income -5.11%-42.94M43.05%-10.9M-46.13%-10.85M-98.22%-11.53M-14.00%-9.66M-141.48%-40.85M-202.81%-19.14M-6.66%-7.42M-888.10%-5.82M-177.95%-8.47M
Net income continuous Operations -5.11%-42.94M43.05%-10.9M-46.13%-10.85M-98.22%-11.53M-14.00%-9.66M-141.48%-40.85M-202.81%-19.14M-6.66%-7.42M-888.10%-5.82M-177.95%-8.47M
Minority interest income
Net income attributable to the parent company -5.11%-42.94M43.05%-10.9M-46.13%-10.85M-98.22%-11.53M-14.00%-9.66M-141.48%-40.85M-202.81%-19.14M-6.66%-7.42M-888.10%-5.82M-177.95%-8.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -5.11%-42.94M43.05%-10.9M-46.13%-10.85M-98.22%-11.53M-14.00%-9.66M-141.48%-40.85M-202.81%-19.14M-6.66%-7.42M-888.10%-5.82M-177.95%-8.47M
Basic earnings per share 2.80%-1.3947.76%-0.35-34.62%-0.35-85.00%-0.370.00%-0.32-116.67%-1.43-191.30%-0.67-8.33%-0.26-566.67%-0.2-128.57%-0.32
Diluted earnings per share 2.80%-1.3947.76%-0.35-34.62%-0.35-85.00%-0.370.00%-0.32-116.67%-1.43-191.30%-0.67-8.33%-0.26-566.67%-0.2-128.57%-0.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg